Identification of a sulfonamide series of CCR2 antagonists
摘要:
A series of sulfonamide CCR2 antagonists was identified by high-throughput screening. Management of molecular weight and physical properties, in particular moderation of lipophilicity and study of pK(a), yielded highly potent CCR2 antagonists exhibiting good pharmacokinetic properties and improved potency in the presence of human plasma. (C) 2010 Elsevier Ltd. All rights reserved.
Pyridinyl Sulfonamide Modulators of Chemokine Receptors
申请人:Cleary Pamela A.
公开号:US20080293720A1
公开(公告)日:2008-11-27
The present invention relates to compounds of following formula:
or pharmaceutically acceptable salts thereof; pharmaceutical compositions containing them, and their use in the treatment of disorders mediated by the CCR-2 receptor.
PYRIDINYL SULFONAMIDE MODULATORS OF CHEMOKINE RECEPTORS
申请人:GLAXO GROUP LIMITED
公开号:EP1962847A2
公开(公告)日:2008-09-03
BENZOFURAN-2-SULFONAMIDE DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS
申请人:ALLERGAN, INC.
公开号:EP2820010B1
公开(公告)日:2018-05-09
BENZOFURAN-2-SULFONAMIDES PYRIDINE DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS
申请人:ALLERGAN, INC.
公开号:US20130231339A1
公开(公告)日:2013-09-05
The present invention relates to novel benzofuran-2-sulfonamide pyridine derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of chemokine receptors.